Randal Halfmann

Randal Halfmann

Auto-generated profile, based on publicly available information

Randal Halfmann

Stowers Institute for Medical Research, Kansas City, MO 64110, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in Cell
Verified
Journal Article
Closed access
SASimon Alberti
Simon Alberti
RHRandal Halfmann
Randal Halfmann
OKOliver King
Oliver King
AKAtul Kapila
Atul Kapila
SLSusan Lindquist
Susan Lindquist

1 March 2014 in Cell
Verified
Journal Article
Closed access
XCXin Cai
Xin Cai
JCJueqi Chen
Jueqi Chen
HXHui Xu
Hui Xu
SLSiqi Liu
Siqi Liu
QJQiu-Xing Jiang
Qiu-Xing Jiang
ZCZhijian J. Chen
Zhijian J. Chen

15 February 2012 in Nature
Verified
Journal Article
Closed access
PDF file
RHRandal Halfmann
Randal Halfmann
DJDaniel F. Jarosz
Daniel F. Jarosz
SJSandra K. Jones
Sandra K. Jones
ACAmelia Chang
Amelia Chang
ALAlex K. Lancaster
Alex K. Lancaster
SLSusan Lindquist
Susan Lindquist

29 October 2010 in Science
Verified
Journal Article
Closed access
PDF file
RHRandal Halfmann
Randal Halfmann
SLSusan Lindquist
Susan Lindquist
Prions are an unusual form of epigenetics: Their stable inheritance and complex phenotypes come about through protein folding rather than nucleic acid–associated changes. With intimate ties to protein homeostasis and a remarkable sensitivity to stress, prions are a robust mechanism that links environmental extremes with the acquisition and inheritance of new traits.

1 March 2013 in Cell
Verified
Journal Article
Closed access
DHDaniel L. Holmes
Daniel L. Holmes
ALAlex K. Lancaster
Alex K. Lancaster
SLSusan Lindquist
Susan Lindquist
RHRandal Halfmann
Randal Halfmann

1 January 2010
Verified
Book Chapter
Open access
SASimon Alberti
Simon Alberti
RHRandal Halfmann
Randal Halfmann
SLSusan Lindquist
Susan Lindquist
Protein aggregates are associated with a variety of debilitating human diseases, but they can have functional roles as well. Both pathological and nonpathological protein aggregates display tremendous diversity, with substantial differences in aggregate size, morphology, and structure. Among the different aggregation types, amyloids are particularly remarkable, because of their high degree of order and their ability to form self-perpetuating conformational states. Amyloids form the structural basis for a group of proteins called prions, which have the ability to generate new phenotypes by a simple switch in protein conformation that does not involve changes in the sequence of the DNA. Although protein aggregates are notoriously difficult to study, recent technological developments and, in particular, the use of yeast prions as model systems, have been very instrumental in understanding fundamental aspects of aggregation. Here, we provide a range of biochemical, cell biological and yeast genetic methods that are currently used in our laboratory to study protein aggregation and the formation of amyloids and prions.